How Has the Hereditary Genetic Testing Market Evolved Historically and What is its Current Size?
The hereditary genetic testing market has seen considerable growth due to a variety of factors.
• There has been a significant increase in the size of the hereditary genetic testing market in the past few years. The market, which was valued at $21.47 billion in 2024, is set to rise to $23.88 billion in 2025, registering a compound annual growth rate (CAGR) of 11.3%.
This growth in the historic period is associated with factors like increasing cases of inherited diseases, advancements in healthcare informatics, the popularity of telemedicine, rise in awareness campaigns, and an increase in the number of genetic testing platforms.
What Is The Projected Growth Of The Hereditary Genetic Testing Template Market?
The hereditary genetic testing market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the hereditary genetic testing market is predicted to experience a rapid expansion. It's anticipated to escalate to a value of $36.23 billion by 2029 with a compound annual growth rate (CAGR) of 11.0%.
Several factors including the escalating incidences of cancer, the increasing occurrence of genetic disorders, growing demand for diagnostic procedures, the rising acceptance of personalized medicine, and an increase in the number of clinical trials contribute to the growth expected during the forecast period. Technological advances, the rise of whole-genome sequencing, the incorporation of genetic data, the shift towards personalized medicine, and the adoption of non-invasive prenatal testing are key trends potentially shaping the market in the forecast period.
What Are The Key Drivers Fueling Growth In The Hereditary Genetic Testing Market?
The escalating incidence rate of cancer is anticipated to boost the expansion of the hereditary genetic testing market. Cancer is characterized as a group of illnesses with abnormal cell growth that has the potential to encroach upon or spread to different body parts. The rising occurrence of cancer can be accredited to elements such as the aging population, changes in lifestyle habits, pollutants in the environment, genetic inclinations, and refinement in diagnostic procedures. Hereditary genetic testing contributes to cancer prevention by detecting genetic alterations linked with elevated risk, thereby facilitating early detection and personalized prevention approaches. For example, data from the Australian Institute of Health and Welfare, a government organization based in Australia, reveals that in Australia, the count of diagnosed cancer cases rose from 156,781 in 2021 to 160,570 in 2022, showcasing a year-over-year increase. Consequently, the escalating incidence of cancer is fueling the expansion of the hereditary genetic testing market.
What Are The Principal Market Segments In The Global Hereditary Genetic Testing Industry?
The hereditary genetic testing market covered in this report is segmented –
1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies
Subsegments:
1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes and Congenital Diseases, Diagnostic Testing For Cancer and Tumor Profiling
5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities and Side Effects, Personalized Medicine and Treatment Optimization
6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing
Pre-Book The Hereditary Genetic Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Hereditary Genetic Testing Market?
Leading firms in the hereditary genetic testing sector are concentrating their efforts on creating innovative genomic solutions, including multi-cancer multigene panels, to improve early identification and tailor-made treatment methods. These multi-cancer multigene panels are particularly useful as they conduct concurrent analysis of numerous genes to identify genetic variations linked to different cancer types, consequently assisting in early detection and individualized therapy. As a case in point, Exact Sciences Corporation, an American company that specializes in cancer screening and diagnostic trials, in February 2024, introduced the Riskguard hereditary cancer examination. This test provides a personalized gene-specific and familial cancer threat report by merely using a blood or saliva specimen to test for 10 prevalent cancers. Not only does it assist in grasping the risk of cancer, establishing screening and treatment schemes, and evaluating family hazards, but it also helps to adapt treatment for patients already diagnosed with cancer and enhances risk classification for those with a pedigree of cancer by identifying actionable genetic differences.
Who Are the Key Players In The Hereditary Genetic Testing Market?
Major companies operating in the hereditary genetic testing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Amgen Inc.
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Qiagen N.V.
• Exact Sciences Corporation
• Fulgent Genetics Inc.
• BioReference Laboratories Inc.
• BGI Group
• Invitae Corporation
• NeoGenomics Laboratories Inc.
• 23andMe Inc.
• MyHeritage Ltd.
• Color Health Inc.
• MedGenome Inc.
• SOPHiA GENETICS SA
• Devyser AB
• Mapmygenome India Ltd.
• Igenomix S.L.
What Are The Regional Insights Into The Hereditary Genetic Testing Market?
North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
